Stay updated on UNCOVER-2: Guselkumab Clinical Trial
Sign up to get notified when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.

Latest updates to the UNCOVER-2: Guselkumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior funding-status notice (Revision: v3.4.1). These are routine site maintenance updates that do not alter the study details on the page.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a government-funding notice stating that the information on the site may not be up to date and providing links to cc.nih.gov and opm.gov for status updates. Updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.2%

- Check48 days agoChange DetectedUI and metadata updates include Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, with deletions of the previous labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. This appears to be a metadata update and does not alter study details or results.SummaryDifference0.0%

- Check84 days agoChange DetectedLocations were updated: new sites were added across the US, Australia, and Canada, and several existing sites were removed. This reflects a revision of the study's geographic coverage.SummaryDifference2%

Stay in the know with updates to UNCOVER-2: Guselkumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.